Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01676051 · ClinicalTrials.gov registry record
Surgical Prep in Hand Surgery
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 240
- Enrollment target
NCT01676051: Completed study, sponsored by University of Pittsburgh.
NCT01676051 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 240 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01676051 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The purposes of this study are to identify the common bacterial flora on the hand and evaluate the efficacy of readily available skin-preparation solutions in the elimination of bacterial pathogens from the surgical site following skin preparation. The null hypothesis is that there is no difference in the efficacy of Chloraprep, Duraprep, and betadine in pre-operative skin preparation in clean, elective hand surgery cases.
Interventions
- OTHER Skin culture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-10 |
What the finished NCT01676051 record still lists
NCT01676051 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Skin culture is the first listed.
NCT01676051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01676051 about?
NCT01676051 is a clinical study titled "Surgical Prep in Hand Surgery". The purposes of this study are to identify the common bacterial flora on the hand and evaluate the efficacy of readily available skin-preparation solutions in the elimination of bacterial pathogens from the surgical site following skin preparation. The null hypothesis is that there is no difference ...
What is the current status of trial NCT01676051?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2012-12. Estimated completion is 2017-10.
What interventions are being tested in trial NCT01676051?
The interventions under investigation include: Skin culture (OTHER).
Who is sponsoring clinical trial NCT01676051?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia